Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 12 November 2024
Accepted: 27 February 2025
First Online: 10 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: ML has received institutional grants by IPSEN Pharma, Nordic Nanovector, Novartis, and Pentixapharm. No other potential conflicts of interest relevant to this article exist.